IL-1 receptor antagonist improves knee function of acute knee injuries with an ACL tear .
This report has been verified
by one or more authors of the
original publication.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254).
Osteoarthritis Cartilage. 2012 Apr;20(4):271-8. Epub 2012 Jan 1011 patients with acute knee injuries, occurring within 30 days of evaluation and presenting with an ACL tear, were randomized to receive an intraarticular injection with an IL-1 receptor antagonist (IL-1Ra) or saline. Authors hypothesized that injection with IL-1Ra would improve KOOS pain and functional scores over a 2 week follow-up period prior to operative reconstruction. Results indicated that the IL-1Ra group demonstrated a significant improvement from baseline measures over the 2 week period; whereas, the placebo group did not have a similar improvement.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
